CYP17A1 Polyclonal Antibody

CYP17A1 Polyclonal Antibody

The CYP17A1 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of CYP17A1 protein expression. This antibody is produced through a rigorous process, ensuring its high affinity and specificity towards the target protein.

CYP17A1, also known as cytochrome P450 17A1, plays a crucial role in steroidogenesis by catalyzing the conversion of pregnenolone and progesterone to their respective 17-hydroxy derivatives, ultimately leading to the production of androgens and estrogens. Dysregulation of CYP17A1 has been implicated in various diseases, including hormone-dependent cancers and disorders of sexual development.

The CYP17A1 Polyclonal Antibody has been extensively validated for its performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits exceptional sensitivity and specificity, enabling accurate and reliable detection of CYP17A1 protein expression in various biological samples.

This antibody is manufactured using state-of-the-art techniques and undergoes stringent quality control measures to ensure batch-to-batch consistency and reproducibility. It is supplied as a liquid formulation, ready for immediate use, and is compatible with a wide range of experimental conditions.

In summary, the CYP17A1 Polyclonal Antibody is a valuable tool for researchers studying steroidogenesis, hormone-dependent diseases, and related fields. Its high specificity, sensitivity, and reliability make it an indispensable asset in the quest for a deeper understanding of CYP17A1 function and its implications in human health and disease.